Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radioisotope Labeling Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN113817003B details stable tritium labeling for catalpol. Enables cost reduction in pharmaceutical intermediate manufacturing and ensures supply chain reliability for ADME studies.
Advanced synthesis of double-labeled Furmonertinib for ADME studies. Enhances tracer sensitivity and supply chain reliability for pharmaceutical R&D teams.